VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $43,655,000 | -66.1% | 196,511 | -69.7% | 1.10% | -68.9% |
| Q1 2015 | $128,913,000 | -28.5% | 649,042 | -48.5% | 3.55% | -15.6% |
| Q4 2014 | $180,409,000 | -16.7% | 1,260,633 | -23.6% | 4.21% | -15.5% |
| Q3 2014 | $216,623,000 | +64.8% | 1,651,090 | +58.4% | 4.99% | +89.7% |
| Q2 2014 | $131,469,000 | +23.2% | 1,042,410 | +28.7% | 2.63% | +35.9% |
| Q1 2014 | $106,748,000 | +1363.1% | 809,743 | +1202.9% | 1.94% | +1216.3% |
| Q4 2013 | $7,296,000 | +12.2% | 62,148 | -0.3% | 0.15% | -6.4% |
| Q3 2013 | $6,501,000 | -73.9% | 62,308 | -78.4% | 0.16% | -69.6% |
| Q2 2013 | $24,884,000 | +193.2% | 289,077 | +155.5% | 0.52% | +84.0% |
| Q1 2013 | $8,487,000 | – | 113,134 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |